Search for stock quotes, financial statistics and more
Research Capital analyst Andre Greg McLeish reiterated a “Buy” rating and $3.50 price target on ... Read More
Research Capital analyst Greg McLeish said in a July 29 update that Cannara Biotech (Cannara Biotech... Read More